Tasso Announces Renewal of SOC 2 Type II Compliance Certification 

Completion of SOC 2 Type II audit certifies the continued security of Tasso platforms  

 

SEATTLE – November 12, 2024 – Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, today announced the successful renewal of their SOC 2 Type II compliance certification with an unqualified opinion, also known as a clean report, following a rigorous independent audit. The SOC 2 Type II audit is conducted by independent, third-party auditors to determine whether a company is maintaining enterprise-level data security through its operations, controls, and processes. This renewal highlights Tasso’s continuing commitment to meeting the highest industry standards and demonstrates the company’s ability to securely manage client data. 

The audit was conducted by Prescient Assurance, a leader in security and compliance attestation for B2B and SaaS companies worldwide. 

Tasso provides a variety of end-to-end logistics services as part of its Tasso Care® blood collection solutions platform. Renewal of SOC 2 Type II compliance certification, the industry gold standard, ensures that client data is safe across Tasso’s online platforms and API. 

“Tasso is committed to protecting sensitive patient data at the highest industry standards,” said Ben Casavant, PhD, CEO and Co-Founder of Tasso. “This SOC 2 Type II renewal demonstrates our continued commitment to security and privacy across our platforms.” 

 

 

About Tasso 

Tasso is an emerging healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company’s devices enable simple, convenient, and virtually painless blood collection for users. Tasso technology has the power to bring healthcare anywhere, any time. Headquartered in Seattle, Washington, Tasso is privately held and funded by grants, investments, and co-development deals with various industry leaders. For more information, please visit www.tassoinc.com. 

  

Media Contact 

Dina Schneider 

(206) 822-4186 x1016 

media@tassoinc.com 

Next
Next

Tasso, Inc.’s Survey Unveils One in Three Patients Delay Diagnostic Blood Tests — Anxiety, Pain and Inconvenience of Traditional Phlebotomy Lead to Patients Missing Routine Care